660 related articles for article (PubMed ID: 8257884)
1. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
[TBL] [Abstract][Full Text] [Related]
2. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
[TBL] [Abstract][Full Text] [Related]
3. Child mortality following standard, medium or high titre measles immunization in West Africa.
Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
[TBL] [Abstract][Full Text] [Related]
4. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
[TBL] [Abstract][Full Text] [Related]
5. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.
Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M
Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263
[TBL] [Abstract][Full Text] [Related]
6. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
[TBL] [Abstract][Full Text] [Related]
7. Excess mortality after early exposure to measles.
Aaby P; Andersen M; Knudsen K
Int J Epidemiol; 1993 Feb; 22(1):156-62. PubMed ID: 8449637
[TBL] [Abstract][Full Text] [Related]
8. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
[TBL] [Abstract][Full Text] [Related]
9. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
[TBL] [Abstract][Full Text] [Related]
10. Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
Hansen JS; Thysen SM; Rodrigues A; Martins C; Fisker AB
BMC Public Health; 2018 Aug; 18(1):984. PubMed ID: 30086732
[TBL] [Abstract][Full Text] [Related]
11. [Measles vaccination and age].
Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
Ugeskr Laeger; 1994 Oct; 156(40):5857-61. PubMed ID: 7985279
[TBL] [Abstract][Full Text] [Related]
12. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.
Aaby P; Lisse IM; Whittle H; Knudsen K; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
Epidemiol Infect; 1994 Apr; 112(2):413-20. PubMed ID: 8150016
[TBL] [Abstract][Full Text] [Related]
14. Routine vaccinations and child survival in a war situation with high mortality: effect of gender.
Aaby P; Jensen H; Garly ML; Balé C; Martins C; Lisse I
Vaccine; 2002 Nov; 21(1-2):15-20. PubMed ID: 12443658
[TBL] [Abstract][Full Text] [Related]
15. Childhood mortality among users and non-users of primary health care in a rural west African community.
Velema JP; Alihonou EM; Gandaho T; Hounye FH
Int J Epidemiol; 1991 Jun; 20(2):474-9. PubMed ID: 1917252
[TBL] [Abstract][Full Text] [Related]
16. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
Waibale P; Bowlin SJ; Mortimer EA; Whalen C
Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
[TBL] [Abstract][Full Text] [Related]
17. Child mortality after high-titre measles vaccines: prospective study in Senegal.
Garenne M; Leroy O; Beau JP; Sene I
Lancet; 1991 Oct; 338(8772):903-7. PubMed ID: 1681265
[TBL] [Abstract][Full Text] [Related]
18. Measles incidence, case fatality, and delayed mortality in children with or without vitamin A supplementation in rural Ghana.
Dollimore N; Cutts F; Binka FN; Ross DA; Morris SS; Smith PG
Am J Epidemiol; 1997 Oct; 146(8):646-54. PubMed ID: 9345118
[TBL] [Abstract][Full Text] [Related]
19. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
[TBL] [Abstract][Full Text] [Related]
20. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study.
Fisker AB; Hornshøj L; Rodrigues A; Balde I; Fernandes M; Benn CS; Aaby P
Lancet Glob Health; 2014 Aug; 2(8):e478-87. PubMed ID: 25103521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
